These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 2967932

  • 1. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K, Gunn T, Woodfield DG.
    N Z Med J; 1987 Jul 08; 100(827):412-4. PubMed ID: 2967932
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore.
    Oon CJ, Tan KL, Goh KT, Wong-Yong L, Viegas O, McCarthy T, Chan SH, Lee HP.
    J Infect; 1986 Nov 08; 13(3):255-67. PubMed ID: 2947953
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Asian Pac J Allergy Immunol; 1986 Jun 08; 4(1):33-6. PubMed ID: 3730058
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Helv Paediatr Acta; 1984 Aug 08; 39(3):231-6. PubMed ID: 6242403
    [Abstract] [Full Text] [Related]

  • 6. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.
    Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, Ma HK.
    Lancet; 1984 Apr 28; 1(8383):921-6. PubMed ID: 6143868
    [Abstract] [Full Text] [Related]

  • 7. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ, Tsai YT, Lee SD, Yeh CL, Wang JY, Chiang BN, Wu TC, Yeh PS, Goudeau A, Coursaget P.
    Hepatogastroenterology; 1985 Apr 28; 32(2):65-8. PubMed ID: 3159639
    [Abstract] [Full Text] [Related]

  • 8. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM, del Canho R, Voogd M, Heijtink RA, Schalm SW.
    Vaccine; 1994 Sep 28; 12(12):1059-63. PubMed ID: 7998413
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Asian Pac J Allergy Immunol; 1988 Dec 28; 6(2):107-10. PubMed ID: 2975491
    [Abstract] [Full Text] [Related]

  • 10. Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report.
    Zanetti AR, Dentico P, Del Vecchio Blanco C, Sagnelli E, Villa E, Ferroni P, Bergamini F.
    J Med Virol; 1986 Apr 28; 18(4):327-34. PubMed ID: 2940333
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus.
    Nair PV, Weissman JY, Tong MJ, Thursby MW, Paul RH, Henneman CE.
    Gastroenterology; 1984 Aug 28; 87(2):293-8. PubMed ID: 6376265
    [Abstract] [Full Text] [Related]

  • 14. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML, Kang LY, Rankin JG, Coates RA, Corey PN, Hu ZH, Zhou TK, Yuan GJ, Yao FL.
    Int J Epidemiol; 1992 Jun 28; 21(3):564-73. PubMed ID: 1386063
    [Abstract] [Full Text] [Related]

  • 15. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers.
    Lee CY, Huang LM, Chang MH, Hsu CY, Wu SJ, Sung JL, Safary A.
    Pediatr Infect Dis J; 1991 Apr 28; 10(4):299-303. PubMed ID: 1829515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of hepatitis B by immunization of the newborn infant--a long-term follow-up study in Stockholm, Sweden.
    Sangfelt P, Reichard O, Lidman K, von Sydow M, Forsgren M.
    Scand J Infect Dis; 1995 Apr 28; 27(1):3-7. PubMed ID: 7784811
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
    Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Chitinand S, Sakulramrung R, Tannirundorn Y.
    Vaccine; 1990 Mar 28; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
    [Abstract] [Full Text] [Related]

  • 19. Postnatal infectivity of hepatitis B surface antigen-carrier mothers.
    Beasley RP, Hwang LY.
    J Infect Dis; 1983 Feb 28; 147(2):185-90. PubMed ID: 6827135
    [Abstract] [Full Text] [Related]

  • 20. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM, Lelie PN, Wong VC, Kuhns MC, Reesink HW.
    Lancet; 1989 Feb 25; 1(8635):406-10. PubMed ID: 2563788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.